Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Alder Biopharmaceuticals files Initial public offering - Form S-1/A

Friday, 25 Apr 2014 09:15am EDT 

Alder Biopharmaceuticals Inc:Initial public offering of 7,150,000 shares of common stock.Offering price is expected to be between $13.00 and $15.00 per share.Applies for the listing of common stock on The NASDAQ Global Market under the symbol ALDR.Underwriters have an option to purchase a maximum of 1,072,500 additional shares to cover over-allotments.Estimate the net proceeds from this offering to be about $90.7 mln, assuming an initial public offering price of $14.00 per share.Expects to use the proceeds of this offering for ongoing clinical program for ALD403 and for preclinical product development activities, working capital and other general corporate purposes. 

Company Quote

21 May 2015